As of November 2024 Allergy Therapeutics has 670.36M shares outstanding, a increase of 4.26% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 670.36M | 4.26% |
2022 | 642.99M | 0.59% |
2021 | 639.19M | 0.47% |
2020 | 636.17M | - |